Difference between revisions of "Vinblastine (Velban)"
Jump to navigation
Jump to search
m |
m |
||
| Line 9: | Line 9: | ||
*[http://www.chemocare.com/chemotherapy/drug-info/Vinblastine.aspx Vinblastine (Velban) patient drug information (Chemocare)]<ref>[http://www.chemocare.com/chemotherapy/drug-info/Vinblastine.aspx Vinblastine (Velban) patient drug information (Chemocare)]</ref> | *[http://www.chemocare.com/chemotherapy/drug-info/Vinblastine.aspx Vinblastine (Velban) patient drug information (Chemocare)]<ref>[http://www.chemocare.com/chemotherapy/drug-info/Vinblastine.aspx Vinblastine (Velban) patient drug information (Chemocare)]</ref> | ||
*[http://www.uptodate.com/contents/vinblastine-patient-drug-information Vinblastine (Velban) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/vinblastine-patient-drug-information Vinblastine (Velban) patient drug information (UpToDate)]</ref> | *[http://www.uptodate.com/contents/vinblastine-patient-drug-information Vinblastine (Velban) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/vinblastine-patient-drug-information Vinblastine (Velban) patient drug information (UpToDate)]</ref> | ||
| + | |||
| + | ==Diseases for which it is used== | ||
| + | *[[Aggressive Non-Hodgkin lymphoma]] | ||
| + | *[[Bladder cancer]] | ||
| + | *[[Breast cancer]] | ||
| + | *[[Hodgkin lymphoma]] | ||
| + | *[[Hodgkin lymphoma, nodular lymphocyte-predominant]] | ||
| + | *[[Melanoma]] | ||
| + | *[[Non-small cell lung cancer]] | ||
| + | *[[Testicular cancer]] | ||
==Also known as== | ==Also known as== | ||
| Line 59: | Line 69: | ||
[[Category:Microtubule inhibitors]] | [[Category:Microtubule inhibitors]] | ||
[[Category:Vinca alkaloids]] | [[Category:Vinca alkaloids]] | ||
| + | |||
[[Category:Aggressive Non-Hodgkin lymphoma medications]] | [[Category:Aggressive Non-Hodgkin lymphoma medications]] | ||
[[Category:Bladder cancer medications]] | [[Category:Bladder cancer medications]] | ||
| + | [[Category:Breast cancer medications]] | ||
[[Category:Hodgkin lymphoma medications]] | [[Category:Hodgkin lymphoma medications]] | ||
[[Category:Hodgkin lymphoma, nodular lymphocyte-predominant medications]] | [[Category:Hodgkin lymphoma, nodular lymphocyte-predominant medications]] | ||
Revision as of 15:03, 19 September 2014
General information
Class/mechanism: Vinca alkaloid, inhibits microtubule formation in the mitotic spindle, causing cell cycle arrest in metaphase.[1][2]
Route: IV
Extravasation: vesicant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Patient drug information
- Vinblastine (Velban) patient drug information (Chemocare)[3]
- Vinblastine (Velban) patient drug information (UpToDate)[4]
Diseases for which it is used
- Aggressive Non-Hodgkin lymphoma
- Bladder cancer
- Breast cancer
- Hodgkin lymphoma
- Hodgkin lymphoma, nodular lymphocyte-predominant
- Melanoma
- Non-small cell lung cancer
- Testicular cancer
Also known as
| Synonyms | ||||
|---|---|---|---|---|
| Alkaban-AQ | Blastovin | Cellblastin | Chlorhexamide | Cytoblastine |
| Erbablas | Exal | Exal 1 | Faulblastina | Lemblastine |
| Periblastine | Rabinefil | Trav Vinblastine | Velban | Velbastine |
| Velbe | Vinblasin | Vinblastin | Vinblastin-Teva | Vinblastina |
| Vinblastina Filaxis | Vinblastine Comp | Vinblastine Sulfate | Vinblastine Sulphate | Vinblastine Tillot |
| Vinblastine Wyeth Pharmaceutic | Vinblastin Kyorin | vincaleukoblastine | VLB | |
References
Categories:
- Drug index
- Chemotherapy
- Vesicant chemotherapy
- Microtubule inhibitors
- Vinca alkaloids
- Aggressive Non-Hodgkin lymphoma medications
- Bladder cancer medications
- Breast cancer medications
- Hodgkin lymphoma medications
- Hodgkin lymphoma, nodular lymphocyte-predominant medications
- Melanoma medications
- Non-small cell lung cancer medications
- Testicular cancer medications